Pulmonary coccidioidomycosis

Seminars in Respiratory and Critical Care Medicine

Volumn 29, Issue 2, 2008, Pages 166-173

  Spinello, Irene M ^a   Munoz, Augustine ^a   Johnson, Royce H ^a  

^a KERN MEDICAL CENTER   (United States)

Author keywords

Complicated pulmonary coccidioidomycosis; Fibrocavitary coccidioidomycosis; Progressive primary coccidioidomycosis; Pulmonary coccidioidomycosis; Residual pulmonary coccidioidomycosis

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CORTICOSTEROID; FLUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ADULT RESPIRATORY DISTRESS SYNDROME; CLINICAL FEATURE; COCCIDIOIDAL FUNGEMIA; COCCIDIOIDOMYCOSIS; DIAGNOSTIC TEST; FUNGEMIA; HUMAN; LIVER TOXICITY; LUNG CAVITATION; LUNG NODULE; MILIARY COCCIDIOIDAL INFECTION; NEPHROTOXICITY; ORGAN TRANSPLANTATION; PNEUMONIA; PREGNANCY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SEROLOGY;

ANTIFUNGAL AGENTS; COCCIDIOIDOMYCOSIS; FEMALE; HUMANS; LUNG DISEASES, FUNGAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 41149123581     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1063855     Document Type: Review

References (47)

1. Posadas A. Ensayo anatomopatologico sobre una neoplasia considerada como micosis fungoidea. An Circ Méd Argent 1892:15-18
2. Rixford E, Gilchrist TC. Two cases of protozoan (coccidioidal) infection of the skin and other organs. Johns Hopkins Hosp Rep 1896:209-268
3. Dickson EC. Coccidioidomycosis; the preliminary acute infection with fungus coccidioides. JAMA 1938;111:1362-1364
4. Gifford MA, Buss WC, Douds RJ. Data on Coccidioides fungus infection, Kern County, 1900-1936. In: Kern County Health Department, Annual Report, 1936-1937:39-54
5. Ophüls W. Further observations on a pathogenic mould formerly described as a protozoon (Coccidioides immitis, Coccidioides pyogenes). J Exp Med 1905;6:443-486
6. Fischer MC, Koenig GL, White TJ, Taylor JW. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia 2002;94:73-84
7. Stevens DA. Coccidioidomycosis. N Engl J Med 1995;332:1077-1082
8. Johnson RH, Munoz AD, Ragland AS. Soil borne illnesses. In: Lessenger J, ed. Handbook of Agricultural Medicine. New York: Springer-Verlag; 2005
9. Petersen LR, Marshall SL, Barton-Dickson C, et al. Coccidioidomycosis among workers at an archaeological site, northeastern Utah. Emerg Infect Dis 2004;10:637-642
10. Ampel NM. Coccidioidomycosis in persons infected with HIV type 1. Clin Infect Dis 2005;41:1174-1178
11. Wright PW, Pappagiannis D, Wilson M, et al. Donor-related coccidioidomycosis in organ transplant recipients. Clin Infect Dis 2003;37:1265-1269
12. Blair JE, Smilack JD, Caples SM. Coccidioidomycosis in patients with hematologic malignancies. Arch Intern Med 2005;165:113-117
13. Crum NF, Lederman ER, Stafford CM, et al. Coccidioidomycosis: a descriptive survey of a reemerging disease: clinical characteristics and emerging controversies. Medicine (Baltimore) 2004;83:149-175
14. Deresinski SC, Pappagianis D, Stevens D. Association of ABO blood group and outcome of coccidioidal infections. Sabouraudia 1979;17:261-264
15. Rosenstein NE, Emery KW, Werner SB, et al. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern county, California, 1995-1996. Clin Infect Dis 2001;32:708-714
16. Johnson RH, Caldwell JW, Welch G, Einstein HE. The great coccidioidomycosis epidemic: clinical features. In: Proceedings of the 5th International Conference. Stanford University, August 24-27, 1994:77-87
17. Bayer AS. Fungal pneumonias; pulmonary coccidioidal syndromes, I: Primary and progressive primary coccidioidal pneumonias-diagnostic therapeutic, and prognostic considerations, Chest 1981;79:575-583
18. Lonky SA, Catanzaro A, Moser KM, Einstein H. Acute coccidioidal pleural effusion. Am Rev Respir Dis 1976;114:681-688
19. Bayer AS. Fungal pneumonias: pulmonary coccidioidal syndromes, II: Miliary, nodular, and cavitary pulmonary coccidioidomycosis; chemotherapeutic and surgical considerations. Chest 1981;79:686-691
20. Anstead GM, Graybill JR. Coccidioidomycosis. Infect Dis Clin North Am 2006;20:621-643
21. Galgiani JN. Coccidioidomycosis. West J Med 1993;159:153-171
22. Winn RE, Johnson R, Galgiani JN, Butler C, Pluss J. Cavitary coccidioidomycosis with fungus ball formation: diagnosis by fiberoptic bronchoscopy with coexistence of hyphae and spherules. Chest 1994;105:412-416
23. Galgiani JN, Ampel NM, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis 2005;41:1217-1223
24. Arsura EL, Kilgore WB. Miliary coccidioidomycosis in the immunocompetent. Chest 2000;117:404-409
25. Spinello IM, Johnson RH. A 19-year-old pregnant woman with a skin lesion and respiratory failure. Chest 2006;130:611-615
26. Shibli M, Ghassibi J, Hajal R, O'Sullivan M. Adjunctive corticosteroids therapy in acute respiratory syndrome owing to disseminated coccidioidomycosis. Crit Care Med 2002;30:1896-1898
27. Sajit S, Spinello IM, Munoz A, Johnson RH. Respiratory failure in pulmonary coccidioidomycosis: is there a role for steroids?. Proceedings of the 48th annual coccidioidomycosis study group meeting; April 3, 2004; Rosarito, Mexico
28. Bozzette SA, Sattler FR, Chiu J, et al. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med 1990;323:1451-1457
29. Rempe S, Sachdev MS, Bhakta R, Pineda-Roman M, Vaz A, Carlson RW. Coccidioides immitis fungemia: clinical features and survival in 33 adult patients. Heart Lung 2007;36:64-71
30. Ahmed AJ, Kruse JA, Haupt MT, Chandrasekar PH, Carlson RW. Hemodynamic responses to gram-positive versus gram-negative sepsis in critically ill patients with and without circulatory shock. Crit Care Med 1991;19:1520-1525
31. Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis 2001;33:1536-1544
32. Blair JE. Coccidioidal pneumonia, arthritis, and soft tissue infection after kidney transplantation. Transpl Infect Dis 2004;6:74-76
33. Logan JL, Blair JE, Galgiani JN. Coccidioidomycosis complicating solid organ transplantation. Semin Respir Infect 2001;16:251-256
34. Tripathy U, Yung GL, Kriett JM, et al. Donor transfer of pulmonary coccidioidomycosis in lung transplantation. Ann Thorac Surg 2002;73:306-308
35. Blair JE, Douglas DD, Mulligan DC. Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area. Transpl Infect Dis 2003;5:3-8
36. Miller MB, Hendren R, Gilligan PH. Posttransplantation disseminated coccidioidomycosis acquired from donor lungs. J Clin Microbiol 2004;42:2347-2349
37. Hall KA, Sethi GK, Rosado LJ, et al. Coccidioidomycosis and heart transplantation. J Heart Lung Transplant 1993;12:525-526
38. Pappagianis D. Epidemiology of coccidioidomycosis. In: Stevens D, ed. Coccidioidomycosis. New York: Plenum; 1980:63-85
39. Crum NF, Ballon-Landa G. Coccidioidomycosis in pregnancy: case report and review of the literature. Am J Med 2006;119:993.e11-17
40. Ostrosky-Zeichner L, Marr KA, Rex JH, et al. Amphotericin B: time for a new "gold standard". Clin Infect Dis 2003;37:415-425
41. Deresinski SC. Coccidioidomycosis: efficacy of new agents and future prospects. Curr Opin Infect Dis 2001;14:693-696
42. Hostetler JS, Heykants J, Clemons KV, et al. Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations. Antimicrob Agents Chemother 1993;37:2224-2227
43. McCarthy KL, Playford G, Looke DFM, Whitby M. Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy. Clin Infect Dis 2007;44:e55-e56
44. Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. N Engl J Med 1999;340:764-771
45. Graybill JR, Stevens DA, Galgiani JN, Dismukes WE, Cloud GA. Itraconazole treatment of coccidioidomycosis. NIAID Mycoses Study Group. Am J Med 1990;89:282-290
46. Galgiani JN, Stevens DA, Graybill JR, Dismukes WE, Cloud GA. Ketoconazole therapy of progressive coccidioidomycosis: comparison of 400 and 800 mg doses and observations at higher doses. Am J Med 1988;84:603-610
47. Catanzaro A, Galgiani JN, Levine BE, et al. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. Am J Med 1995;98:249-256